Skip to content Skip to footer

Development of a technology to enhance Dendritic Cell-Targeted mRNA vaccine delivery (2026-2028)

Experts

Dr Christopher Howard

Advance Qld Industry Res Fellow
Australian Institute for Bioengineering and Nanotechnology
Christopher Howard
Christopher Howard

Associate Professor Seth Cheetham

Affiliate of ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR)
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Australian Institute for Bioengineering and Nanotechnology
Director, National Biologics Facility and AIBN Group Leader
Australian Institute for Bioengineering and Nanotechnology
Seth Cheetham
Seth Cheetham

Honorary Professor Kristen Radford

Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Kristen Radford
Kristen Radford

Dr Liam O'Brien

Postdoctoral Research Fellow - mRNA Cancer Vaccines
Australian Institute for Bioengineering and Nanotechnology
Affiliate Professional Staff
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Liam O'Brien
Liam O'Brien

Dr James Humphries

Affiliate of ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR)
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Australian Institute for Bioengineering and Nanotechnology
Postdoctoral Research Fellow
Australian Institute for Bioengineering and Nanotechnology
James Humphries

Professor Kristofer Thurecht

Institute Director
Office of the Provost
Centre Director of ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Australian Institute for Bioengineering and Nanotechnology
Kristofer Thurecht
Kristofer Thurecht